Application of 3D-QSAR and virtual screening methods for design of novel antidepressants affecting serotonin transporters and histamine H3 receptors
Само за регистроване кориснике
2016
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
Depression is the most common psychiatric disease. There are indications that dual histamine H3 antagonsts with
selective serotonin reuptake inhibition activity could be promising novel class of more effective antidepressants.1 The
aim of this in silico study was to identify the novel dual acting antidepressants with suitable pharmacokinetic
properties, by using computer-aided drug discovery tools. Two 3D-QSAR models were developed ...
Извор:
COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) POLY-PHARMACOLOGY EXPANDING PAUL EHRLICH’S MAGIC BULLET CONCEPT ,BOOK OF THE ABSTRACTS, November 19-20, 2016, 88-88Издавач:
- COST ACTION CA15135 (European Cooperation in Science and Technology)
Финансирање / пројекти:
- Синтеза, квантитативни однос између структуре и дејства, физичко-хемијска карактеризација и анализа фармаколошки активних супстанци (RS-MESTD-Basic Research (BR or ON)-172033)
Напомена:
- First WG Meeting BOOK OF THE ABSTRACTS COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) POLY-PHARMACOLOGY EXPANDING PAUL EHRLICH’S MAGIC BULLET CONCEPT Hotel Novotel Budapest Danube - Budapest, November 19-20, 2016
Институција/група
PharmacyTY - CONF AU - Vučićević, Jelica AU - Đoković, Nemanja AU - Filipić, Slavica AU - Nikolić, Katarina AU - Agbaba, Danica PY - 2016 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5401 AB - Depression is the most common psychiatric disease. There are indications that dual histamine H3 antagonsts with selective serotonin reuptake inhibition activity could be promising novel class of more effective antidepressants.1 The aim of this in silico study was to identify the novel dual acting antidepressants with suitable pharmacokinetic properties, by using computer-aided drug discovery tools. Two 3D-QSAR models were developed ... PB - COST ACTION CA15135 (European Cooperation in Science and Technology) C3 - COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) POLY-PHARMACOLOGY EXPANDING PAUL EHRLICH’S MAGIC BULLET CONCEPT ,BOOK OF THE ABSTRACTS, November 19-20 T1 - Application of 3D-QSAR and virtual screening methods for design of novel antidepressants affecting serotonin transporters and histamine H3 receptors SP - 88 EP - 88 UR - https://hdl.handle.net/21.15107/rcub_farfar_5401 ER -
@conference{ author = "Vučićević, Jelica and Đoković, Nemanja and Filipić, Slavica and Nikolić, Katarina and Agbaba, Danica", year = "2016", abstract = "Depression is the most common psychiatric disease. There are indications that dual histamine H3 antagonsts with selective serotonin reuptake inhibition activity could be promising novel class of more effective antidepressants.1 The aim of this in silico study was to identify the novel dual acting antidepressants with suitable pharmacokinetic properties, by using computer-aided drug discovery tools. Two 3D-QSAR models were developed ...", publisher = "COST ACTION CA15135 (European Cooperation in Science and Technology)", journal = "COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) POLY-PHARMACOLOGY EXPANDING PAUL EHRLICH’S MAGIC BULLET CONCEPT ,BOOK OF THE ABSTRACTS, November 19-20", title = "Application of 3D-QSAR and virtual screening methods for design of novel antidepressants affecting serotonin transporters and histamine H3 receptors", pages = "88-88", url = "https://hdl.handle.net/21.15107/rcub_farfar_5401" }
Vučićević, J., Đoković, N., Filipić, S., Nikolić, K.,& Agbaba, D.. (2016). Application of 3D-QSAR and virtual screening methods for design of novel antidepressants affecting serotonin transporters and histamine H3 receptors. in COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) POLY-PHARMACOLOGY EXPANDING PAUL EHRLICH’S MAGIC BULLET CONCEPT ,BOOK OF THE ABSTRACTS, November 19-20 COST ACTION CA15135 (European Cooperation in Science and Technology)., 88-88. https://hdl.handle.net/21.15107/rcub_farfar_5401
Vučićević J, Đoković N, Filipić S, Nikolić K, Agbaba D. Application of 3D-QSAR and virtual screening methods for design of novel antidepressants affecting serotonin transporters and histamine H3 receptors. in COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) POLY-PHARMACOLOGY EXPANDING PAUL EHRLICH’S MAGIC BULLET CONCEPT ,BOOK OF THE ABSTRACTS, November 19-20. 2016;:88-88. https://hdl.handle.net/21.15107/rcub_farfar_5401 .
Vučićević, Jelica, Đoković, Nemanja, Filipić, Slavica, Nikolić, Katarina, Agbaba, Danica, "Application of 3D-QSAR and virtual screening methods for design of novel antidepressants affecting serotonin transporters and histamine H3 receptors" in COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) POLY-PHARMACOLOGY EXPANDING PAUL EHRLICH’S MAGIC BULLET CONCEPT ,BOOK OF THE ABSTRACTS, November 19-20 (2016):88-88, https://hdl.handle.net/21.15107/rcub_farfar_5401 .